- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07627607
Early Prediction of ICU Hypotension Using Machine Learning (ICU-HypoAI)
A Prospective Observational Machine Learning Study for the Early Prediction of Hypotension in Adult Intensive Care Unit Patients
Studie Overzicht
Gedetailleerde beschrijving
Hypotension is a frequent hemodynamic event in critically ill patients and may occur before clear clinical deterioration is recognized. Earlier identification of patients at risk may support closer clinical attention and more timely evaluation. This study is designed as a prospective, observational machine learning study in adult intensive care unit patients.
Routinely available ICU data will be collected at five-minute intervals, including systolic, mean, and diastolic non-invasive blood pressure, heart rate, medication-dose entries, and fluid-balance records. These data will be used to construct time-dependent features reflecting recent values, short-term changes, and rolling trends. Hypotension will be defined at each five-minute time point as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg.
The primary prediction horizon will be 30 minutes. Separate secondary analyses will evaluate 5- and 15-minute prediction horizons. A gradient-boosted decision-tree model will be developed and internally validated using patient-level data partitioning to avoid assigning observations from the same patient to both training and validation sets. Model performance will be assessed using discrimination, classification performance, and calibration measures. Feature-importance analyses will be used to describe the variables contributing to model predictions.
The study is observational. No treatment, medication, device, alarm, or clinical decision will be assigned by the study protocol. The prediction model will be developed and evaluated using collected data and will not be used to guide real-time patient management during the study period.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Kütahya
-
Kütahya, Kütahya, Turkije (Türkiye), 43100
- Kütahya City Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age 18 years or older
- Admission to the adult intensive care unit during the study period
- Length of stay in the intensive care unit of at least 24 hours
- Availability of routine intensive care unit monitoring data
- Availability of non-invasive blood pressure and heart rate measurements recorded during ICU monitoring
- Availability of medication-dose and/or fluid-balance records during ICU monitoring
Exclusion Criteria:
- Age younger than 18 years
- Length of stay in the intensive care unit of less than 24 hours
- Absence of usable blood pressure monitoring data
- Records with irrecoverable timestamp inconsistencies
- Insufficient monitoring duration for feature construction and future outcome labeling
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Adult Intensive Care Unit Patients
Adult patients admitted to the intensive care unit who are monitored during routine clinical care.
Routinely collected non-invasive blood pressure, heart rate, medication-dose, and fluid-balance data will be used for machine learning model development and internal validation.
No treatment or clinical intervention will be assigned by the study protocol.
|
Routinely collected intensive care unit data, including non-invasive blood pressure, heart rate, medication-dose records, and fluid-balance data, will be recorded and analyzed for development and internal validation of a machine learning model.
The study does not assign any treatment, medication, device, alarm, or clinical decision.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Area Under the Receiver Operating Characteristic Curve for 30-Minute Hypotension Prediction
Tijdsspanne: From enrollment through the end of ICU monitoring, up to 4 months
|
Discriminative performance of the machine learning model for predicting hypotension 30 minutes before its occurrence.
Hypotension will be defined as systolic blood pressure below 90 mmHg, mean arterial pressure below 65 mmHg, or diastolic blood pressure below 60 mmHg at a five-minute observation point.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Area Under the Receiver Operating Characteristic Curve for 5- and 15-Minute Hypotension Prediction
Tijdsspanne: From enrollment through the end of ICU monitoring, up to 4 months
|
Discriminative performance of separate machine learning models for predicting hypotension at 5-minute and 15-minute prediction horizons.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
|
Classification Performance of the Hypotension Prediction Model
Tijdsspanne: From enrollment through the end of ICU monitoring, up to 4 months
|
Classification performance of the machine learning model will be assessed using sensitivity, specificity, positive predictive value, negative predictive value, and F1 score at predefined classification thresholds.
|
From enrollment through the end of ICU monitoring, up to 4 months
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2026/03-15
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .